Objective-Several physiological stimuli activate smooth muscle cell (SMC) G q PCRs (G q protein-coupled receptors) to cause vasoconstriction. As a protective mechanism against excessive vasoconstriction, SMC G q PCR stimulation invokes endothelial cell vasodilatory signaling. Whether Ca 2+ influx in endothelial cells contributes to the regulation of G q PCR-induced vasoconstriction remains unknown. Ca 2+ influx through TRPV4 (transient receptor potential vanilloid 4) channels is a key regulator of endothelium-dependent vasodilation. We hypothesized that SMC G q PCR stimulation engages endothelial TRPV4 channels to limit vasoconstriction. Approach and Results-Using high-speed confocal microscopy to record unitary Ca 2+ influx events through TRPV4 channels (TRPV4 sparklets), we report that activation of SMC α 1 ARs (alpha 1 -adrenergic receptors) with phenylephrine or thromboxane A 2 receptors with U46619 stimulated TRPV4 sparklets in the native endothelium from mesenteric arteries. Activation of endothelial TRPV4 channels did not require an increase in Ca 2+ as indicated by the lack of effect of L-type Ca 2+ channel activator or chelator of intracellular Ca 2+ EGTA-AM. However, gap junction communication between SMCs and endothelial cells was required for phenylephrine activation or U46619 activation of endothelial TRPV4 channels. Lowering inositol 1,4,5-trisphosphate levels with phospholipase C inhibitor or lithium chloride suppressed phenylephrine activation of endothelial TRPV4 sparklets. Moreover, uncaging inositol 1,4,5-trisphosphate profoundly increased TRPV4 sparklet activity. In pressurized arteries, phenylephrine-induced vasoconstriction was followed by a slow, TRPV4-dependent vasodilation, reflecting activation of negative regulatory mechanism. Consistent with these data, phenylephrine induced a significantly higher increase in blood pressure in TRPV4 −/− mice. Conclusions-These results demonstrate that SMC G q PCR stimulation triggers inositol 1,4,5-trisphosphate-dependent activation of endothelial TRPV4 channels to limit vasoconstriction. Visual Overview-An online visual overview is available for this article.
A ctivation of G q PCRs (G q protein-coupled receptors) in vascular smooth muscle cells (SMCs) has emerged as a central mechanism for vasoconstriction in response to intravascular pressure and neurohumoral mediators. [1] [2] [3] [4] [5] [6] Sympathetic nerve stimulation predominantly activates G q -coupled α 1 ARs (alpha 1 -adrenergic receptors) in SMCs to cause vasoconstriction. Although α 1 AR-mediated vasoconstriction is an important component of the flight-or-fight response, excessive vasoconstriction can lower the blood flow to target tissues and elevate blood pressure to abnormal levels. In this regard, endothelial cells (ECs) play an important role in limiting the vasoconstriction induced by SMC α 1 ARs. SMC to EC heterocellular communication evokes endothelial vasodilatory mechanisms to regulate vasoconstriction. [7] [8] [9] [10] However, the individual signaling elements of this negative regulatory mechanism remain unclear.
Recent studies reveal a crucial role for endothelial projections to SMCs, or myoendothelial projections (MEPs), in negative regulation of vasoconstriction in response to α 1 AR activation. [8] [9] [10] MEPs are specialized structures that contain key elements for endothelium-dependent vasodilation, including IP 3 Rs (inositol 1,4,5-trisphosphate [IP 3 ] receptors), in the endoplasmic reticulum (ER) and intermediate/small conductance Ca 2+ -sensitive K + (IK/SK) channels and cation channels at the cell membrane. [11] [12] [13] [14] Moreover, myoendothelial gap junctions (MEGJs) at the end of the MEPs 15 allow for the movement of second messengers and ionic charges between SMCs and ECs. [7] [8] [9] 16, 17 Localized increases in Ca 2+ at the MEPs have been associated with IK/SK channel activation and endothelium-derived hyperpolarization (EDH) in small, resistancesized arteries. 11, 12, 18 Activation of G q PCRs in SMCs causes vasoconstriction predominantly via 2 second messengers, IP 3 and Ca
2+
. The diffusion of IP 3 and Ca 2+ from SMCs to ECs via MEGJs can increase Ca 2+ inside the MEPs directly or via activation of IP 3 Rs on the ER membrane. [7] [8] [9] [10] 16, 17 Whether the diffusion of second messengers from SMCs to ECs after SMC G q PCR activation also invokes Ca 2+ influx pathways at the MEPs has not been elucidated.
Previous studies have established that Ca 2+ influx signals through TRPV4 (transient receptor potential vanilloid 4) channels localized at MEPs regulate EDH-mediated vasodilation in resistance-sized mesenteric, cremaster, and cerebral arteries. 11, 14, 18, 19 TRPV4 channels are Ca
-selective cation channels that are activated by flow/shear stress, G q protein signaling, or changes in temperature and pressure. 11, 20, 21 We recently showed that local, unitary Ca 2+ influx signals through endothelial TRPV4 channels, termed TRPV4 sparklets, activate IK/SK channels to dilate resistance-sized mesenteric arteries (MAs). 14, 18, 22 Moreover, TRPV4 channels are potentiated by Ca 2+ and have a binding site for IP 3 . 14,23-27 Therefore, we hypothesized that SMC G q PCR activation engages endothelial TRPV4 channels via IP 3 and Ca 2+ to limit vasoconstriction. In the current study, we used differential kinetics and pharmacology to isolate IP 3 R-dependent Ca 2+ signals and TRPV4 sparklets in the native endothelium. Moreover, we provide the first evidence that SMC G q PCR agonists trigger endothelial TRPV4-IK/SK signaling to negatively regulate vasoconstriction. Although SMC G q PCR-induced activation of TRPV4 channels requires SMC-EC communication via gap junctions, it is independent of the movement of Ca 2+ from SMCs to ECs or IP 3 R-mediated Ca 2+ release in ECs. Our findings support a novel paradigm that IP 3 is an endogenous activator of TRPV4 channels in the native endothelium and point to IP 3 -mediated activation of endothelial TRPV4 channels as a key negative regulatory mechanism for SMC G q PCR-induced vasoconstriction.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. Figure 1A , left). Based on the fractional fluorescence (F/F 0 ) traces, Ca 2+ signals under basal conditions could be broadly categorized into short, spike-shaped signals with one distinct peak and longer-lasting signals with square, discrete amplitudes. Consistent with previous reports on IP 3 R-mediated Ca 2+ signals in GCaMP2 mice, 8, 12 the spike-shaped events had a duration of <300 ms. These events were inhibited by cyclopiazonic acid (CPA, 20 μmol/L), an inhibitor of sarcoplasmic reticulum/ER Ca 2+ -ATPase, but not by the selective TRPV4 channel inhibitor GSK2193874 (GSK219, 100 nmol/L) or 0 mmol/L extracellular Ca 2+ ( Figure 1A , middle and right), indicating Ca 2+ release from the ER. On the other hand, signals with square amplitudes lasted >300 ms and had a plateau phase with multiple data points at the peak ( Figure 1B, left) . A multi-Gaussian fit to the all-points histogram of square events yielded a quantal level of 0.185 ΔF/F 0 , consistent with the quantal level for TRPV4 sparklets 14, 18 ( Figure 1B, middle) . Moreover, the square signals were inhibited by GSK219 and 0 mmol/L extracellular Ca Figure 1C) . Interestingly, SMC α 1 AR activation also caused a 3-fold increase in TRPV4 sparklet activity and a 2.5-fold increase in the number of sparklet sites per field ( Figure 1D ). GSK219 abolished the phenylephrineinduced increases in TRPV4 sparklet activity but not the increase in IP 3 R Ca 2+ signals ( Figure 1C and 1D ). These results confirmed that phenylephrine increases the activity of both TRPV4 sparklets and IP 3 R-mediated Ca 2+ signals. Figure 1A display TRPV4 Ca 2+ sparklets under basal conditions or with GSK219 (100 nmol/L). Middle, All-points histogram was constructed from F/F 0 traces obtained from 3 mesenteric arteries (MAs) and was fit with a multi-Gaussian curve. The quantal levels (ie, step-wise increases in amplitudes) were obtained from the peaks of the multi-Gaussian curve. Right, Averaged TRPV4 sparklet activity is presented in the absence or presence of GSK219, CPA, or 0 mmol/L extracellular Ca 2+ , or CPA. TRPV4 sparklet activity is expressed as NP O per site and number of sparklet sites per field. N represents the number of channels at a site and P O is the openstate probability of the channels. *#P<0.05 vs baseline or CPA, respectively. C, Left, Representative F/F 0 traces indicate IP 3 Figure 2C ), suggesting that TRPV4 sparklets were being activated independent of IP 3 R-mediated Ca 2+ release. Moreover, in the presence of a membrane-permeable Ca 2+ chelator, EGTA-AM (5 μmol/L), phenylephrine was able to activate TRPV4 sparklets to a similar extent ( Figure 2D ), thus, ruling out a role for Ca 2+ in phenylephrine activation of TRPV4 sparklets. Consistent with previous studies, 10,17 a strong immunostaining of α 1D AR subtype was observed in SMC layer, but not in EC layer in MAs ( Figure 2E ). We therefore postulated that SMC α 1D ARs activate endothelial TRPV4 channels via SMC-EC heterocellular communication. Another SMC G q PCR agonist U46619 (a thromboxane A 2 receptor agonist, 1 μmol/L) also caused a 5-fold activation of endothelial TRPV4 sparklets ( Figure 2F ), supporting the idea that multiple activators of G q protein signaling in SMCs stimulate endothelial TRPV4 sparklets.
Results

Distinct
α 1 AR Activation of Endothelial TRPV4 Sparklets Requires Phospholipase C Signaling and Movement of Second Messengers Through MEGJs
IP 3 and Ca 2+ are the 2 major second messengers generated by α 1 AR signaling via phospholipase C (PLC) activation in SMCs. Both these second messengers can diffuse to the EC side via MEGJs. [7] [8] [9] [10] 16 Therefore, we determined whether PLC signaling and MEGJ function are necessary for the activation of TRPV4 sparklets by SMC α 1 ARs. In the presence of U73122 (a PLC inhibitor, 3 μmol/L), TRPV4 sparklet activity was not altered by phenylephrine ( Figure 3A) . Moreover, gap junction uncoupling agents 18β-glycyrrhetinic acid (18βGA; 30 μmol/L) 28,29 or 1-heptanol (heptanol, 1 mmol/L) 30-32 also abolished phenylephrine-induced increase in TRPV4 sparklet activity ( Figure 3B ; Figure IA in the online-only Data Supplement). U73122, 18βGA, or heptanol, by itself, did not alter the activity of TRPV4 sparklets ( Figure IA and IB in the online-only Data Supplement). These results suggested that second messengers generated by PLC signaling may diffuse to the ECs through MEGJs and activate TRPV4 sparklets. Lack of effect of phenylephrine or U46619 on TRPV4 sparklet activity in the presence of 18βGA or heptanol ruled out a direct effect of these compounds on EC TRPV4 channel function. Phenylephrine and U46619 were able to increase SMC Ca 2+ in the presence of CPA ( Figure IIA and IIB in the online-only Data Supplement). Increase in SMC Ca 2+ by phenylephrine or U46619 was not altered by 18βGA ( Figure IIC and IID in the online-only Data Supplement), supporting the concept that the effect of phenylephrine or U46619 is initiated exclusively in the SMCs. Figure 3C , bottom) or endothelial TRPV4 sparklet activity ( Figure 3D ). These results indicate that phenylephrine-induced increase in endothelial TRPV4 sparklet activity is not because of increased SMC Ca 2+ .
Increase in SMC Ca
IP 3 Activates TRPV4 Sparklets by Increasing Burst Open Times of TRPV4 Channels
While phenylephrine-induced increase in TRPV4 sparklets was independent of SMC Ca 2+ , the PLC-and MEGJ-dependent nature of TRPV4 sparklet activation by phenylephrine suggested a role for SMC-derived IP 3 . In this regard, previous studies have stipulated that the movement of IP 3 from SMCs to ECs can increase endothelial Ca 2+ . 8, 9, 16, 34 A recent study in expression system unraveled a binding site for IP 3 on TRPV4 channel and showed that binding of IP 3 to this site increases channel activity. 26 We, therefore, hypothesized that Figure 3A, 3B, and 3D) . N represents the number of channels at a site and P O is the open state probability of the channels. Data are presented as mean±SEM.
SMC-derived IP 3 activates endothelial TRPV4 channels after α 1 AR activation. The presence of lithium chloride (inositol monophosphatase inhibitor, 1 mmol/L), which has been commonly used to lower intracellular IP 3 levels, [35] [36] [37] [38] inhibited phenylephrine-and U46619-induced activation of TRPV4 sparklets, suggesting an IP 3 -dependent nature of TRPV4 sparklet activation by phenylephrine and U46619 ( Figure 4A ). To determine whether IP 3 can activate TRPV4 sparklets in native endothelium, we uncaged IP 3 using 10 ms pulse of ultraviolet light. En face mouse MAs were simultaneously incubated with fluo-4 and caged IP 3 (2 μmol/L). CPA (20 μmol/L) was added to prevent IP 3 -induced Ca 2+ release from the ER. Ultraviolet light alone did not alter the activity of TRPV4 sparklets ( Figure 4B ). Uncaging IP 3 using ultraviolet light increased sparklet activity per site by 5-fold and number of sites per field by 3-fold, respectively ( Figure 4C ), an effect that was completely suppressed in the arteries pretreated with GSK219 ( Figure 4C ). Cooperative openings of TRPV4 channels in a cluster has emerged as an important regulatory mechanism for TRPV4 channel activity.
14 An analysis of coupling strength among TRPV4 channels in a cluster showed that IP 3 did not alter the cooperative openings (κ values) of TRPV4 channels in a cluster ( Figure 4D ). Majority of TRPV4 sparklets represent bursts of TRPV4 channel openings. 39, 40 Uncaging IP 3 increased the burst open times for each quantal level by 2-to 4-fold ( Figure 4E ). Taken together, these results suggest that SMC-derived IP 3 activates endothelial TRPV4 channels in response to α 1 AR signaling by increasing channel open times.
SMC α 1 AR Signaling Activates TRPV4 Sparklets Exclusively at MEPs
Because MEGJs between endothelial and SMCs form at the ends of MEPs, [41] [42] [43] we postulated that phenylephrine or U46619-induced increase in TRPV4 sparklet activity occurs exclusively at the MEPs. The MEPs are indicated by black holes in the internal elastic lamina ( Figure 5A and 5C). Sparklet sites within 5 μm from the center of a hole in the internal elastic lamina were considered as MEP sparklet sites.
14 Phenylephrine-induced a 3.5-fold increase in TRPV4 sparklet activity at the MEPs but did not affect the sparklet activity at other sites ( Figure 5B) . Similarly, U46619 increased sparklet activity at MEPs by 5.5-fold and did not alter sparklet activity at non-MEP sites ( Figure 5D ). Collectively, these data support the concept that SMC-derived IP 3 locally diffuses through MEGJs and selectively activates TRPV4 channels at the MEPs.
Endothelial TRPV4 Channels Negatively Regulate Phenylephrine-Induced Vasoconstriction
Activation of endothelial TRPV4 sparklets promotes endothelium-dependent vasodilation in small MAs.
14,18 Therefore, we hypothesized that phenylephrine-induced activation of endothelial TRPV4 channels contributes to the feedback regulation of vasoconstriction. Vascular reactivity was assessed in MAs constricted by intravascular pressure of 80 mm Hg. Phenylephrine-induced vasoconstriction peaked at ≈2 minutes after addition of phenylephrine and was followed by a slow vasodilation ( Figure 6A , phenylephrine alone; Table I in the online-only Data Supplement). The vasodilation after phenylephrine-induced vasoconstriction has been attributed to negative feedback regulation by endothelium. 7, 44, 45 The peak vasodilation after phenylephrine was significantly attenuated in the presence of TRPV4 inhibitor GSK219 in endotheliumdenuded arteries and in the MAs from TRPV4 −/− mice ( Figure  6A through 6D) , indicating that endothelial TRPV4 channels are responsible for the vasodilation after phenylephrine-induced vasoconstriction.
In systemic arteries, TRPV4 sparklets activate Ca 2+ -sensitive IK/SK channels to cause vasodilation. 18 Consistent with these prior findings, vasodilation after phenylephrine treatment was significantly reduced in the presence of Tram-34 (1 μmol/L)/apamin (300 nmol/L; IK/SK channel inhibitors; Figure 6A Figure 6C and 6D), indicating that SMC α 1 AR initiates SMC-EC gap junction communication that evokes endothelial TRPV4-IK/SK signaling to cause vasodilation after phenylephrine-induced vasoconstriction. In the presence of CPA, to eliminate IP 3 R-mediated Ca 2+ release in ECs and SMCs, phenylephrine-induced vasoconstriction was followed by a vasodilation similar to that in the absence of CPA ( Figure 6C and 6D, Figure III in the online-only Data Supplement). Moreover, the vasodilation was almost entirely inhibited by GSK219 ( Figure III in the online-only Data Supplement). Thus, TRPV4 channel-dependent vasodilation after phenylephrine addition in the presence of CPA was consistent with that observed in the absence of CPA.
Phenylephrine Induced a Larger Increase in Blood Pressure in TRPV4 Knockout Mice
Radiotelemetric recording of blood pressure showed that the systolic and diastolic blood pressures and heart rate were not different in global TRPV4 knockout mice when compared with the wild-type control mice ( Figure IV in the onlineonly Data Supplement). However, phenylephrine injection 
Discussion
Heterocellular communication between SMCs and ECs is crucial for the regulation of blood pressure and blood flow on a moment-to-moment basis. One EC is structurally surrounded by several SMCs in the arteriolar wall, 46 thus, uniquely positioned to receive signals from SMCs to modulate their contractile state. While the role of endothelium in moderating nerve stimulation-induced vasoconstriction is well established, 7-10,17,34 the individual signaling elements involved in this negative feedback regulation of vasoconstriction remain unclear. In this study, we provide the first evidence that SMC G q protein signaling activates Ca 2+ influx through endothelial TRPV4 channels to negatively regulate vasoconstriction. Moreover, activation of endothelial TRPV4 channels by phenylephrine seems to be independent of increases in SMC Ca 2+ and may represent direct activation of TRPV4 channels by IP 3 transfer from SMCs to ECs via MEGJs. SMC G q PCR activation has emerged as an important mechanism for vasoconstriction in response to intravascular pressure and neurohumoral mediators. [1] [2] [3] [4] [5] [6] Activation of TRPV4 channels in ECs represents an immediate feedback mechanism for the regulation of vasoconstriction caused by SMC G q PCR activation. The negative feedback regulation of vasoconstriction mainly involves activation of endothelial TRPV4-IK/SK signaling. Several vascular disorders including hypertension are characterized by sympathetic overactivation and endothelial dysfunction. 47, 48 Moreover, the function of endothelial TRPV4 channels is impaired in angiotensin II-induced hypertension.
14 An impairment of TRPV4 channel-dependent feedback regulation of vasoconstriction may result in higher vasoconstriction and exacerbate the effects of endothelial dysfunction in vascular disorders.
Intracellular Ca 2+ plays a pivotal role in regulating diverse functions of endothelium. 11, 12, 18, 49, 50 Previous studies of negative feedback regulation of vasoconstriction have mostly focused on IP 3 R-mediated Ca 2+ release in ECs. While endothelial TRPV4 channels have been shown to regulate endothelium-dependent vasodilation in different vascular beds, 11, 14, 18, 19 their role in negative feedback regulation of vasoconstriction remains unknown. Our results represent the first evidence for IP 3 R and TRPV4 Ca 2+ signals as 2 main Ca 2+ signals in native endothelium under basal conditions. Distinct kinetic and pharmacological properties of these 2 signals can be used to obtain greater mechanistic details on how Ca 2+ regulates endothelial function under normal and disease conditions. Moreover, an ability to simultaneously record the 2 signals enables the studies on how they are modulated by physiological stimuli.
MEGJs, an essential component of heterocellular coupling between ECs and SMCs, allow the transfer of small signaling molecules (ie, Ca 2+ and IP 3 ; below 1 kDa of molecular mass). [41] [42] [43] Previous studies have postulated that Ca 2+ and IP 3 produced by SMC G q PCR signaling diffuse to ECs through MEGJs and alter endothelial Ca 2+ signaling. 7, 8, 10, 16, 17, 34 A recent study by Garland et al 10 suggested that Ca 2+ influx through SMC VDCCs increases EC Ca 2+ signals. Although the current study does not exclude the possibility of the Ca 2+ diffusing across MEGJs, an increase in SMC VDCC activity was unable to stimulate endothelial TRPV4 sparklets ( Figure 3D ). Moreover, a similar activation of TRPV4 sparklets by phenylephrine or U46619 in the presence or absence of VDCC blocker nifedipine ( Figure V in the online-only Data Supplement) rules out a role for SMC VDCCs in phenylephrine activation or U46619 activation of TRPV4 sparklets. Garland et al 10 demonstrated that nifedipine completely inhibited the effect of 0.3 μmol/L phenylephrine, but not 3 μmol/L phenylephrine, on endothelial Ca 2+ signals, suggesting VDCC-independent mechanism for the activation of endothelial Ca 2+ signals at higher phenylephrine concentration (3 μmol/L). Consistent with these data, we find that phenylephrine does not activate endothelial TRPV4 sparklets at 0.3 μmol/L (Figure VI in the online-only Data Supplement), and TRPV4 sparklet activation by 1 to 10 μmol/L phenylephrine is not dependent on VDCCs. Thus, it is possible that the activation of endothelial TRPV4 channels by SMC G q PCR signaling is dependent on the concentration of G q PCR agonist, as seen with 1 to 10 μmol/L phenylephrine or 1 μmol/L U46619.
Additionally, lithium chloride (inositol monophosphatase inhibitor; Figure 4A ), PLC inhibition ( Figure 3A) , and uncoupling of gap junctions ( Figure 3B ; Figure I in the onlineonly Data Supplement) attenuated the activation of TRPV4 sparklets by phenylephrine, suggesting that IP 3 generated by SMC G q PCR signaling may cross over to the EC side and activate TRPV4 sparklets. This interpretation is consistent with previous studies demonstrating that IP 3 is the key molecule delivered to ECs after α 1 AR stimulation and results in localized Ca 2+ signals-Ca 2+ pulsars or wavelets-in ECs. 8, 9, 51 In conjunction with the data that IP 3 activated TRPV4 sparklets, these results support the idea that IP 3 crossing over to the EC side not only activates IP 3 R-mediated Ca 2+ signals but also stimulates TRPV4 channels. In this regard, glycyrrhetinic acids (18αGA and 18βGA) have been used to disrupt gap junction coupling between SMCs and ECs in arteries. [52] [53] [54] In particular, the efficacy and potency of 18βGA for blocking vascular gap junctions were found to be much higher than those of 18αGA 28 ; therefore, 18βGA was used in this study to examine whether the delivery of SMC-derived second messengers evokes endothelial TRPV4 channel activity. Heptanol has also been used extensively to suppress gap junction communication. [30] [31] [32] While 18βGA and heptanol ( Figure I in the online-only Data Supplement) did not alter basal TRPV4 sparklet activity or SMC Ca 2+ , both the compounds abolished phenylephrine-induced activation of TRPV4 sparklets, supporting their effectiveness as MEGJ uncoupling agents.
Our results provide the first evidence of IP 3 as an endogenous activator for TRPV4 channel function in native endothelium. The IP 3 -induced increase in TRPV4 sparklet activity was independent of IP 3 R-mediated Ca 2+ release from the ER (Figures 1D and 2C ). How IP 3 activates TRPV4 channels remains unknown. A recent study delineated that the ankyrin repeat domain of TRPV4 channels has an IP 3 binding site, and binding of IP 3 to this site increases TRPV4 channel activity. 26 In addition, IP 3 application considerably increased whole-cell currents evoked by 4α-PDD (4α-phorbol 12,13-didecanoate; an activator of TRPV4 channels) in HEK293 (human embryonic kidney 293) cells.
26 TRPV4 sparklets represent bursts of openings of TRPV4 channels in a cluster. 39, 40 Our results indicate that IP 3 increases the mean burst open times for TRPV4 channels but does not alter the cooperative openings among the channels in a cluster. We, therefore, postulate that SMCderived IP 3 stimulates endothelial TRPV4 channels via a direct interaction that increases the channel open times.
Some of the previous studies have proposed a direct movement of free Ca 2+ from SMCs to ECs as a mechanism for myoendothelial feedback regulation of vasoconstriction. 7, 10 In the current study, an increase in SMC Ca 2+ did not increase endothelial TRPV4 sparklet activity, a result that is in agreement with previous investigations, suggesting that an increase in SMC Ca 2+ does not alter EC Ca 2+ . 8, 34 Although there is evidence suggesting that SMC Ca 2+ diffuses to EC, 7,10 any possible diffusion of Ca 2+ seems to be insufficient to stimulate endothelial TRPV4 channels. Furthermore, a similar activation of endothelial TRPV4 sparklets by phenylephrine in the absence or presence of CPA ( Figures 1D and 2B) , EGTA-AM ( Figure 2D ), and nifedipine ( Figure V in . [60] [61] [62] It is plausible that the MEGJs in mouse MAs are selectively permeable to IP 3 . Taken together, these results suggest that an increase in SMC Ca 2+ is not an essential component for TRPV4 channel activation by phenylephrine.
Phenylephrine-induced vasoconstriction is followed by slow vasodilation, 7, 44, 45 a response that is attributed to myoendothelial feedback regulation. Specifically, phenylephrine induces an increase in endothelial Ca 2+ that activates vasodilatory mechanisms, including NO or IK/SK channel-mediated EDH. [8] [9] [10] 17 Although phenylephrine treatment (1-10 μmol/L) consistently induced the biphasic vasomotor responses in pressurized MAs, the vasodilatory component was abolished in the presence of IK/SK channel inhibitors. It is well documented that endothelium-dependent vasodilation of resistance-sized arteries is primarily controlled by EDH, whereas NO and prostacyclin are the prevailing vasodilators in larger, conduit arteries. 63, 64 The number of MEPs increases inversely with vessel size, 15 supporting the notion that MEP-localized EDH signaling plays a crucial role in resistance-sized arteries. MEPs serve as the cellular platforms that house the biological apparatus, including IK/SK channels and MEGJs necessary for EDHmediated vasodilation. [11] [12] [13] [14] While TRPV4 sparklets can occur at MEP and non-MEP sites, 14 our results that phenylephrine activated TRPV4 sparklets selectively at the MEPs support SMC-EC communication at the MEPs and subsequent activation of EDH signaling. It is likely that IP 3 generated by SMC G q PCR signaling locally diffuses to ECs via MEGJs and initiates EDH signaling by activating TRPV4 channels at the MEPs. Additional inhibition of vasodilation by NO synthase inhibitor in the presence of IK/SK inhibitors may be an indication for a minor role of NO in myoendothelial feedback regulation in MAs (Figure 6 ). Compared with the TRPV4 channel inhibitor, IK/SK channel inhibitors in the absence or presence of l-N G -nitroarginine had a larger effect on the vasodilatory component after phenylephrine, suggesting that the IP 3 R Ca 2+ signal activated by phenylephrine may couple with IK/SK channels and eNOS (endothelial nitric oxide synthase; Figure 6 ).
Several limitations of the present investigation need to be acknowledged: (1) there is no tracking of IP 3 as it moves from SMCs to ECs. While this will be an important area for future investigation, the currently available tools do not allow for accurate tracking of IP 3 in intact arteries. This will require development of reliable IP 3 probes or isotope labeling of SMC IP 3 . (2) Despite the many advantages of en face preparation (more ECs per field of view, higher signal/noise at high imaging speed), it is likely that SMCs and ECs experience different stretch levels in pressurized and en face preparations, and therefore, have different resting membrane potentials. It was observed that the membrane potential of ECs in en face arteries is ≈−45 mV. 12 The SMC membrane potential in en face preparation and EC membrane potential in pressurized arteries are not known. Although the results in en face preparation are consistent with those from diameter studies in pressurized arteries, minor differences in signaling mechanisms because of differences in membrane potentials cannot be ruled out. (3) The Ca 2+ images represent snapshots of 1 minute. In this duration, some cells show Ca 2+ signals, while others are quiescent. Whether this is because of EC heterogeneity or is a function of probability of finding active sites during the recording duration remains unknown. Definitively addressing this possibility may require data acquisition for several hours. The high imaging rates required for recording TRPV4 sparklets and IP 3 R events and the possibility of bleaching the fluorophores or damaging the endothelium limit our ability to record Ca 2+ signals for several hours. (4) Endothelium-specific TRPV4 knockout mice will provide the most direct evidence for the role of TRPV4 channels in negatively regulating phenylephrine-induced vasoconstriction and increase in blood pressure. However, such mice have not been generated. (5) The number of TRPV4 sparklet sites activated by phenylephrine and U46619 seem to be different. This could be because of the differences in the number of sparklet sites under baseline conditions. Indeed, the number of TRPV4 sparklet sites varies from one field to another, while the sparklet activity/site remains unchanged.
In conclusion, our studies reveal that distinct endothelial Ca 2+ signals could be isolated and analyzed under physiological conditions using differential kinetics and pharmacology. Moreover, the study also provides first evidence for a novel endothelial mechanism that acts as a feedback regulator for vasoconstriction induced by SMC G q PCR activation. In agreement with previous studies, this mechanism involves heterocellular communication and transfer of second messengers from SMCs to ECs. This is followed by the activation of EC TRPV4 channels, possibly through the movement of IP 3 from SMCs to ECs and a direct interaction of IP 3 with TRPV4 channels. G q PCR activation is an important mechanism for SMC contraction. Indeed, numerous physiological vasoconstrictors including intravascular pressure (myogenic tone), α 1 AR activation, thromboxane A2 receptor activation, and angiotensin II receptor activation involve G q protein signaling in SMCs.
Activation of EC TRPV4 channels may be a key mechanism that negatively regulates vasoconstriction to these stimuli, thus, preventing excessive vasoconstriction. An abnormal TRPV4 channel-dependent negative feedback regulation of vasoconstriction may result in elevated blood pressure and, therefore, is a potential mechanism that could be targeted for treating hypertension.
